Clinical Trials Browser

Spinal Cord Neoplasms

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

Squamous Cell Carcinoma of Head and Neck

Arthritis, Joint Diseases

Rectal Neoplasms

Uterine Cervical Neoplasms

Rhabdomyosarcoma

Colorectal Neoplasms

Cervical Cancer by FIGO Stage 2018

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Glioblastoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Carcinoma, Non-Small-Cell Lung

Rectal Cancer Patients

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Non-Muscle Invasive Bladder Neoplasms

Glioblastoma

Digestive System Neoplasms

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Adenocarcinoma

Small Cell Lung Carcinoma

Non-Muscle Invasive Bladder Neoplasms

Squamous Cell Carcinoma of Head and Neck

Urinary Bladder Neoplasms, Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

The Effect of Radiotherapy After Separation Surgery for Spinal Metastases

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

REDUCE-30

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

NG-ST

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

TRIUNITE-07

RETHEMCOL

INSIGHT MRL

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

CURB-TKI

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Bemcentinib in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

NoCUT-BC

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

SENTRY

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Spirulina Derivative for Radiation Esophagitis

Neo-Margin

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

SPRINT 2

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

TRAIN

NG101m Adjuvant Therapy in Glioblastoma Patients

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

TAS-102 Plus Radiotherapy in Elderly ESCC

IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

[18F]-AraG PET Imaging in LA HNSCC

STAR

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

DECIDING

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

NACRE-2

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

ZAMBONI

OMEC-5

BRACE

A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

NMN